ACC.26 advanced registration ends Feb. 12 – register now!

Brahmajee K. Nallamothu, MD, FACC

Brahmajee Nallamothu

General Statement of Disclosure:

OWNERSHIP/PARTNERSHIP/PRINCIPAL: AngioInsight(NONE) RESEARCH/RESEARCH GRANTS: Janssen Pharmaceuticals, Inc(SIGNIFICANT)

View Full Disclosure